TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
MPLT

MapLight Therapeutics, Inc.

Healthcare · Biotechnology · —

10.90$ -3.5% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for MapLight Therapeutics, Inc. (MPLT): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 08/13/2026.

Next report 08/13/2026
Last report 08/13/2026
Earnings surprise by quarter (%)
Q3 25 · -2,061.6 % 25 Q4 25 · -197.6 % 25 Q1 26 · -22.9 % 26 Q2 26 · 5.7 % 26

EPS estimate beaten

Full history 1 of 5 quarters (20%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 08/13/2026 MapLight Therapeutics, Inc. (MPLT): Entry into a Material Definitive Agreement; Results of Operations and Financial Condition; Unregistered Sales of Equity Securities; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/27/2026 MapLight Therapeutics, Inc. (MPLT): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?